II
VRTX icon

Inspire Investing’s Vertex Pharmaceuticals VRTX Stock Holding History

Inspire Investing’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-18,755
Closed -$3.78M – 937
2021
Q2 		$3.78M Buy
18,755
+1,477
+9% +$309K 0.5% 37
2021
Q1 		$3.71M Buy
17,278
+4,739
+38% +$1.04M 0.57% 29
2020
Q4 		$2.96M Buy
12,539
+1,937
+18% +$444K 0.66% 18
2020
Q3 		$2.88M Sell
10,602
-182
-2% -$50.2K 0.79% 16
2020
Q2 		$3.13M Buy
10,784
+3,972
+58% +$1.08M 1.08% 12
2020
Q1 		$1.62M Sell
6,812
-995
-13% -$228K 0.65% 16
2019
Q4 		$1.71M Sell
7,807
-846
-10% -$171K 0.61% 26
2019
Q3 		$1.47M Buy
8,653
+1,120
+15% +$198K 0.56% 25
2019
Q2 		$1.38M Buy
7,533
+705
+10% +$123K 0.58% 21
2019
Q1 		$1.26M Buy
6,828
+1,483
+28% +$274K 0.58% 21
2018
Q4 		$886K Buy
5,345
+516
+11% +$89.4K 0.6% 21
2018
Q3 		$931K Buy
4,829
+749
+18% +$133K 0.57% 21
2018
Q2 		$693K Buy
4,080
+2,570
+170% +$398K 0.49% 24
2018
Q1 		$246K Buy
1,510
+192
+15% +$31.4K 0.25% 113
2017
Q4 		$198K Buy
+1,318
New +$195K 0.17% 80

Other funds holding VRTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Inspire Investing's VRTX Position: Q3 2021 in Review

Inspire Investing sold out of Vertex Pharmaceuticals (VRTX) in Q3 2021, closing a stake of 18,755 shares — an estimated $3.78M sold.

Inspire Investing first reported a position in VRTX in Q4 2017 and held it in 15 quarters. The position peaked at $3.78M in Q2 2021. 933 funds tracked by Wall St. Rank hold VRTX as of Q3 2021.

  • Inspire Investing reported no remaining Vertex Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Inspire Investing sold 18,755 Vertex Pharmaceuticals shares in Q3 2021, an estimated $3.78M.
  • Inspire Investing first reported a position in Vertex Pharmaceuticals in Q4 2017 and held it in 15 quarters.
  • Inspire Investing's Vertex Pharmaceuticals position peaked at $3.78M in Q2 2021.
  • 933 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2021.

Based on Inspire Investing's 13F filing for Q3 2021, filed 9 Nov 2021.